MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/genes16111313

Медицинская библиотека · Genes · 2025

FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications.

Doly Nusrat Jahan, Lee Dong Yeul, Tahsin Kazi Nafisa, Akhter Jhuma, Sultana Shahana, Khatun Julekha, Chua Sue-Zann, Banu A Tasleema, Chen Qingfeng, Iqbal Jabed

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The E26 transformation-specific (ETS) transcription factor Friend Leukemia Integration 1 (FLI1) has been linked to breast cancer aggressiveness, stromal remodeling, and immune modulation, yet the regulatory mechanisms governing its activity remain poorly defined. Of note, various studies have shown that EWS-FLI1-mediated transcription programs are facilitated via direct recruitment and binding of the NuRD-LSD1 complex, regulating its associated gene targets. Furthermore, LSD1 inhibition exhibited reverse transcriptional profiles driven by ETS-FLI and reduced in vivo tumorigenesis in cancers.

METHODS

We evaluated FLI1 expression across multiple invasive breast carcinoma (IBC) cohorts to determine its prognostic significance and associations with stromal features. In parallel, we investigated FLI1 regulation in humanized breast cancer mouse models treated with an LSD1 inhibitor.

RESULTS

High FLI1 expression was associated with advanced histological grade in IBC, consistent with an oncogenic function. FLI1-high tumors also exhibited elevated stromal and immune scores, indicating a role in remodeling the tumor microenvironment. Additionally, LSD1 inhibition downregulated FLI1 target genes involving angiogenesis and invasion.

CONCLUSIONS

These findings highlight the dual role of FLI1: tumor-intrinsic FLI1 promotes proliferation and invasion, whereas its transcriptional regulation in tumor and endothelial compartments likely reflects LSD1 dependence. Collectively, our results support a mechanistic model in which LSD1-FLI1 crosstalk is involved in immune and stromal remodeling, positioning FLI1 as both a marker of tumor aggressiveness and a potential predictor of response to epigenetic therapies in breast cancer.

Для цитирования: Doly Nusrat Jahan, Lee Dong Yeul, Tahsin Kazi Nafisa, Akhter Jhuma, Sultana Shahana, Khatun Julekha, Chua Sue-Zann, Banu A Tasleema, Chen Qingfeng, Iqbal Jabed. FLI1 Expression in Invasive Breast Carcinoma: Clinicopathological Correlations and Prognostic Implications.. Genes. 2025. DOI: 10.3390/genes16111313.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.